Get started
Award

75N91022F00007

Funded outputs count: 4
Funder award ID: 75N91022F00007
OpenAlex ID: G8564603901
SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses
2026 · Stephen D. Schmidt, Rahul Subramanian, et al. · Nature Communications
PDF
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
2026 · Fei Heng, Craig A. Magaret, et al. · Vaccine · 1
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
2025 · David J. Diemert, Daniel S. Graciaa, et al. · Vaccine · 1
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
2023 · Nadine G Rouphael, Angela R Branche, et al. · The Journal of Infectious Diseases · 3
PDF
Year
Topic